Guangdong True Health Medical Technology Development Co. Ltd. Class H

As of June 30, 2026, Guangdong True Health Medical Technology Development Co. Ltd. Class H carries a market capitalization of 14.26B, placing it among publicly traded companies globally. Its enterprise value stands at 13.71B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Guangdong True Health Medical Technology Development Co. Ltd. Class H's next confirmed earnings release is scheduled for March 3, 2027.

As of June 30, 2026, Guangdong True Health Medical Technology Development Co. Ltd. Class H has 35.65M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Guangdong True Health Medical Technology Development Co. Ltd. Class H maintains a current ratio of 14.25, meaning it holds 14.3x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

These figures are as of the close on October 22, 2026.

As of June 30, 2026, Guangdong True Health Medical Technology Development Co. Ltd. Class H holds 566.59M in cash and equivalents against 19.54M in total debt, resulting in a net debt position of -522.65M. Total book value stands at 627.41M, with working capital of 592.71M providing operational flexibility.